Key Data Points

Primary metrics and data points about Gilead Sciences.
Current Price: $97.72
Prev Close: $98.13
Open: $98.16
Bid: $97.83
Ask: $97.94
Day's Range: $95.38 - $98.16
52wk Range: $63.50 - $116.83
Volume: 15,116,681
Avg Vol 10,107,782
Market Cap: $146B
P/E (ttm): 13.35
EPS (ttm): $7.35
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Gilead Sciences.

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GILD vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Gilead Sciences.
CAPS Rating 5 out of 5
 
3037 Outperform
82 Underperform
CAPS All Stars
 
743 Outperform
12 Underperform

Powered by Motley Fool CAPS


More Details about Gilead Sciences

Primary metrics and data points about Gilead Sciences.

Company Photos

Powered by